Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.

Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M.

Pediatr Transplant. 2012 Sep;16(6):E201-9. doi: 10.1111/j.1399-3046.2012.01699.x. Epub 2012 May 30.

PMID:
22646132
[PubMed - indexed for MEDLINE]
2.

High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder.

Patrick A, Wee A, Hedderman A, Wilson D, Weiss J, Govani M.

J Neurooncol. 2011 Jul;103(3):739-43. doi: 10.1007/s11060-010-0425-0. Epub 2010 Sep 26.

PMID:
20872273
[PubMed - indexed for MEDLINE]
3.

Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.

Bonney DK, Htwe EE, Turner A, Kelsey A, Shabani A, Hughes S, Hughes I, Wynn RF.

Pediatr Blood Cancer. 2012 Mar;58(3):459-61. doi: 10.1002/pbc.23134. Epub 2011 May 16.

PMID:
21584931
[PubMed - indexed for MEDLINE]
4.

Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder.

Czyzewski K, Styczynski J, Krenska A, Debski R, Zajac-Spychala O, Wachowiak J, Wysocki M.

Leuk Lymphoma. 2013 Mar;54(3):503-6. doi: 10.3109/10428194.2012.718342. Epub 2012 Aug 31.

PMID:
22873830
[PubMed - indexed for MEDLINE]
5.

Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

Nabors LB, Palmer CA, Julian BA, Przekwas AM, Kew CE.

Am J Transplant. 2009 May;9(5):1243-8. doi: 10.1111/j.1600-6143.2009.02598.x.

PMID:
19422350
[PubMed - indexed for MEDLINE]
Free Article
6.

Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab.

Kordelas L, Trenschel R, Koldehoff M, Elmaagacli A, Beelen DW.

Onkologie. 2008 Dec;31(12):691-3. doi: 10.1159/000165057. Epub 2008 Nov 14.

PMID:
19060508
[PubMed - indexed for MEDLINE]
7.

Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Wasson S, Zafar MN, Best J, Reddy HK.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83.

PMID:
16703222
[PubMed - indexed for MEDLINE]
8.

Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.

Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.

J Clin Oncol. 2005 Sep 20;23(27):6481-8.

PMID:
16170157
[PubMed - indexed for MEDLINE]
Free Article
9.

Epstein-Barr virus-positive post-transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid.

Boersma MN, van der Zanden A, Laverman GD, Sanders JS, de Vries PA.

Transpl Int. 2012 Nov;25(11):e113-6. doi: 10.1111/j.1432-2277.2012.01552.x. Epub 2012 Aug 21.

PMID:
22909403
[PubMed - indexed for MEDLINE]
10.

Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement.

Hänel M, Fiedler F, Thorns C.

Onkologie. 2001 Oct;24(5):491-4.

PMID:
11694778
[PubMed - indexed for MEDLINE]
11.

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Jagadeesh D, Woda BA, Draper J, Evens AM.

Curr Treat Options Oncol. 2012 Mar;13(1):122-36. doi: 10.1007/s11864-011-0177-x. Review.

PMID:
22241590
[PubMed - indexed for MEDLINE]
12.

Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.

Zimmermann H, Reinke P, Neuhaus R, Lehmkuhl H, Oertel S, Atta J, Planker M, Gärtner B, Lenze D, Anagnostopoulos I, Riess H, Trappe RU.

Cancer. 2012 Oct 1;118(19):4715-24. doi: 10.1002/cncr.27482. Epub 2012 Mar 5.

PMID:
22392525
[PubMed - indexed for MEDLINE]
Free Article
13.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Styczynski J, Einsele H, Gil L, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):383-92. doi: 10.1111/j.1399-3062.2009.00411.x. Epub 2009 Jun 23. Review.

PMID:
19558376
[PubMed - indexed for MEDLINE]
14.

Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.

Banks CA, Meier JD, Stallworth CR, White DR.

Ann Otol Rhinol Laryngol. 2012 May;121(5):291-5. Review.

PMID:
22724273
[PubMed - indexed for MEDLINE]
15.

Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.

Said-Conti V, Amrolia PJ, Gaze MN, Stoneham S, Sebire N, Shroff R, Marks SD.

Pediatr Nephrol. 2013 Oct;28(10):2053-6. doi: 10.1007/s00467-013-2499-3. Epub 2013 Jun 7.

PMID:
23743853
[PubMed - indexed for MEDLINE]
16.

Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.

Mentzer SJ, Perrine SP, Faller DV.

Transpl Infect Dis. 2001 Sep;3(3):177-85. Review.

PMID:
11493400
[PubMed - indexed for MEDLINE]
17.

Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells.

Comoli P, Maccario R, Locatelli F, Valente U, Basso S, Garaventa A, Tomà P, Botti G, Melioli G, Baldanti F, Nocera A, Perfumo F, Ginevri F.

Am J Transplant. 2005 Jun;5(6):1415-22.

PMID:
15888049
[PubMed - indexed for MEDLINE]
Free Article
18.

Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.

van de Glind G, de Graaf S, Klein C, Cornelissen M, Maecker B, Loeffen J.

Pediatr Blood Cancer. 2008 Apr;50(4):886-8.

PMID:
17668865
[PubMed - indexed for MEDLINE]
19.

Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.

Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI.

Curr Oncol Rep. 2010 Nov;12(6):383-94. doi: 10.1007/s11912-010-0132-1. Review.

PMID:
20963522
[PubMed - indexed for MEDLINE]
20.

Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients.

Martin SI, Dodson B, Wheeler C, Davis J, Pesavento T, Bumgardner GL.

Am J Transplant. 2011 May;11(5):1058-63. doi: 10.1111/j.1600-6143.2011.03478.x. Epub 2011 Mar 30.

PMID:
21449943
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk